NEW YORK (TheStreet) -- RATINGS CHANGES
Align (ALGN) was upgraded at Robert Baird to outperform from neutral. Twelve-month price target is $64. Company should see higher near-term shipments, Robert Baird said.
Bed Bath & Beyond (BBBY) was upgraded at Canaccord Genuity to buy. Estimates were also increased, as sales momentum is building, Canaccord Genuity said. Twelve-month price target is $91.Dentsply ( XRAY) was downgraded at Robert Baird to neutral from outperform. Valuation call, as the company lacks near-term catalysts, Robert Baird said.
Synaptics (SYNA) was downgraded at Pacific Crest to sector perform. Company is facing increased competition and lacks near-term catalysts, Pacific Crest said.
Editor's note: To see analysts' stock comments and changes to price targets and earnings estimates, go to "Street Notes," which is available only to Real Money subscribers. To find out how to become a subscriber, please click here.